Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cahill, D.J.
Right arrow Articles by Hull, M.G.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cahill, D.J.
Right arrow Articles by Hull, M.G.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 9, No. 7, pp. 1243-1246, 1994
© 1994 European Society of Human Reproduction and Embryology

research-article

Endocrinology: Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy

D.J. Cahill1,3, S.A. Fountain2, R. Fox1, C.F. Fleming1, P.R. Brinsden2 and M.G.R. Hull1

1University of Bristol Department of Obstetrics and Gynaecology, St. Michael's Hospital Bristol BS2 8EG 2Bourn Hall Clinic Bourn, Cambridge, CB3 7TR, UK

Correspondence: 3To whom correspondence should be addressed

All women undergoing pituitary down-regulation before planned in-vitro fertilization (IVF) treatment in two IVF units were studied to assess the risks of and to pregnancies occurring inadvertently when gonadotrophin-releasing hormone agonists (GnRHa) were used to achieve pituitary desensitization during the luteal phase prior to planned IVF treatment. In 2670 cycles, 25 women conceived (0.9% of cycles). Of these, three resulted in pre-clinical abortions (12%) but there were no clinical abortions, and 22 have ended with live births at term of apparently normal infants. Collation of these and other published data suggest that pregnancy outcome is not adversely affected by GnRHa administration in the luteal phase of the conception cycle.

Key words: early pregnancy/inadvertent GnRH anologue/pregnancy outcome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
D. J. Cahill, J. M. Jenkins, P. W. Soothill, A. Whitelaw, and P. G. Wardle
Quadruplet pregnancy following transfer of two embryos: Case report
Hum. Reprod., February 1, 2003; 18(2): 441 - 443.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.